These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 24887478)

  • 21. Expression pattern of inositol phosphate-related enzymes in rice (Oryza sativa L.): implications for the phytic acid biosynthetic pathway.
    Suzuki M; Tanaka K; Kuwano M; Yoshida KT
    Gene; 2007 Dec; 405(1-2):55-64. PubMed ID: 17961936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
    Croze ML; Soulage CO
    Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of myristylation in HIV-1 Gag assembly.
    Bouamr F; Scarlata S; Carter C
    Biochemistry; 2003 Jun; 42(21):6408-17. PubMed ID: 12767222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of inositol phospholipid and inositol phosphate metabolism in chemoattractant-activated human polymorphonuclear leukocytes.
    Dillon SB; Murray JJ; Uhing RJ; Snyderman R
    J Cell Biochem; 1987 Dec; 35(4):345-59. PubMed ID: 3126197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of an inositol hexakisphosphate (IP6) affinity probe to study the interactome from a colon cancer cell line.
    Yin MX; Catimel B; Gregory M; Condron M; Kapp E; Holmes AB; Burgess AW
    Integr Biol (Camb); 2016 Mar; 8(3):309-18. PubMed ID: 26840369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel nuclear export activity in HIV-1 matrix protein required for viral replication.
    Dupont S; Sharova N; DéHoratius C; Virbasius CM; Zhu X; Bukrinskaya AG; Stevenson M; Green MR
    Nature; 1999 Dec; 402(6762):681-5. PubMed ID: 10604476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of HIV-like particle assembly in vitro by inositol phosphates.
    Campbell S; Fisher RJ; Towler EM; Fox S; Issaq HJ; Wolfe T; Phillips LR; Rein A
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10875-9. PubMed ID: 11526217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme-assisted total synthesis of the optical antipodes D-myo-inositol 3,4,5-trisphosphate and D-myo-inositol 1,5, 6-trisphosphate: aspects of their structure-activity relationship to biologically active inositol phosphates.
    Adelt S; Plettenburg O; Stricker R; Reiser G; Altenbach HJ; Vogel G
    J Med Chem; 1999 Apr; 42(7):1262-73. PubMed ID: 10197969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The major homology region of the HIV-1 gag precursor influences membrane affinity.
    Ebbets-Reed D; Scarlata S; Carter CA
    Biochemistry; 1996 Nov; 35(45):14268-75. PubMed ID: 8916912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfonate protecting groups. Regioselective sulfonylation of myo-inositol orthoesters-improved synthesis of precursors of D- and L-myo-inositol 1,3,4,5-tetrakisphosphate, myo-inositol 1,3,4,5,6-pentakisphosphate and related derivatives.
    Sureshan KM; Shashidhar MS; Praveen T; Gonnade RG; Bhadbhade MM
    Carbohydr Res; 2002 Nov; 337(24):2399-410. PubMed ID: 12493224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of New L-Heptanoylphosphatidyl Inositol Pentakisphosphate Derivatives Targeting the Interaction with HIV-1 Gag by Molecular Modelling Studies.
    Ciftci H; Sever B; Ayan E; Can M; DeMirci H; Otsuka M; TuYuN AF; Tateishi H; Fujita M
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The absence of expression of the three isoenzymes of the inositol 1,4,5-trisphosphate 3-kinase does not prevent the formation of inositol pentakisphosphate and hexakisphosphate in mouse embryonic fibroblasts.
    Leyman A; Pouillon V; Bostan A; Schurmans S; Erneux C; Pesesse X
    Cell Signal; 2007 Jul; 19(7):1497-504. PubMed ID: 17355905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myo-inositol hexakisphosphate degradation by Bifidobacterium infantis ATCC 15697.
    Haros M; Bielecka M; Honke J; Sanz Y
    Int J Food Microbiol; 2007 Jun; 117(1):76-84. PubMed ID: 17462768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates.
    Shen X; Xiao H; Ranallo R; Wu WH; Wu C
    Science; 2003 Jan; 299(5603):112-4. PubMed ID: 12434013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism and biological activities of inositol pentakisphosphate and inositol hexakisphosphate.
    Sasakawa N; Sharif M; Hanley MR
    Biochem Pharmacol; 1995 Jul; 50(2):137-46. PubMed ID: 7543266
    [No Abstract]   [Full Text] [Related]  

  • 36. New tetherable derivatives of myo-inositol 2,4,5- and 1,3,4-trisphosphates.
    Marecek JF; Estevez VA; Prestwich GD
    Carbohydr Res; 1992 Oct; 234():65-73. PubMed ID: 1468081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of electrostatic interaction on the proton-binding behaviour of myo-inositol hexakisphosphate.
    Zuiderweg ER; van Beek GG; de Bruin SH
    Eur J Biochem; 1979 Feb; 94(1):297-306. PubMed ID: 35351
    [No Abstract]   [Full Text] [Related]  

  • 38. Fibrinogen - a possible extracellular target for inositol phosphates.
    Grint T; Riley AM; Mills SJ; Potter BV; Safrany ST
    Messenger (Los Angel); 2012 Dec; 1(2):160-166. PubMed ID: 24749013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possibility of mA.
    Ma E
    Phys Rev D Part Fields; 1994 Feb; 49(3):1663-1665. PubMed ID: 10017148
    [No Abstract]   [Full Text] [Related]  

  • 40. A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication.
    Sever B; Otsuka M; Fujita M; Ciftci H
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.